Latest Articles

Subject

Clinical/Scientific Note
Immune-Mediated Rippling Muscle Disease Associated With Thymoma and Anti-MURC/Cavin-4 Autoantibodies
Juliette Svahn, Laurent Coudert, Nathalie Streichenberger, et al.

December 15, 2022
Diagnostic & Treatment Challenges
MOG Antibody–Associated Disease and Thymic HyperplasiaFrom the National Multiple Sclerosis Society Case Conference Proceedings
Brigitte Hurtubise, Elliot M. Frohman, Steven Galetta, et al.

December 14, 2022
Research Article
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis
María Muñoz-San Martín, Imma Gómez, Ana Quiroga-Varela, et al.

December 09, 2022
Research Article
Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar
Ingo Kleiter, Anthony Traboulsee, Jacqueline Palace, et al.

December 08, 2022
Research Article
Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis
Noemí de Luna, Álvaro Carbayo, Oriol Dols-Icardo, et al.

December 02, 2022
Research Article
Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis
Antoine Philippe Fournier, Olivier Tastet, Marc Charabati, et al.

November 29, 2022
Research Article
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD
Margherita Nosadini, Michael Eyre, Thea Giacomini, et al.

November 29, 2022
Research Article
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
Antonio Farina, Macarena Villagrán-García, Nicolás Lundahl Ciano-Petersen, et al.

November 29, 2022
Research Article
Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis
Eleni S. Vasileiou, Chen Hu, Charles N. Bernstein, et al.

November 23, 2022
Review
Secondary Progressive Multiple SclerosisA Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies
Tjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.

November 22, 2022

Pages